Replies to post #819385 on NorthWest Biotherapeutics Inc (NWBO)

[seekinganswers]

"but the price expectation is tamped down by an absolute worst case scenario where big pharma, market makers and hedge funds control the price so that big pharma has a chance to offer a lowball price to investors"

This statement is utter nonsense and completely false. In fact, if it were true, (which it's not) .... no person with a brain would buy or hold this stock!!!
The trial failed, LP is a crooked CEO, and you have been scammed.
JMHO. GL to all.

[Investor082]

The problem is big pharma is not interested in paying .20 for the company either.

No one was complaining when the share price touched $2.5 after data lock. It stayed between $1 and $2 for over 15 months consecutively. Big pharma was not interested then either.

Roswell Park deal is a good indicator. No big pharma showed interest for a couple of years and hence they dumped it to LP and NWBO for pennies.

Enjoy the endless dilution in pennies throughout 2026! ;)

[beachhyena]

Thanks Doc, the truth is that the shorts are all in way over their heads and the synthetic short position is massive and at a minimum 1.43 billion shares. FTD's will explode this price out of their control if extremely positive news comes in and Retail refuse to sell their shares because the true valuation occurs when recognition that DCVAX-L and DCVAX-D are platform technologies. DCVAX will be rolled out to other cancer indicators a lot faster than people realize and proof of tumor shrinkage by patients receiving DCVAX will explode it's growth into these indications.
Let's look at the true short position once again just to remind Longs on this board what is at stake and why valuations of $1.00 are being thrown around.

NWBO Synthetic Short Position